RLAY

Relay Therapeutics, Inc.

Healthcare›Biotechnology|NASDAQ Global Market|US

Price

$12.54

Market Cap

$2.24B

Beta

1.62

P/E

0.0

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+53.45%

EPS Growth (YoY)+32.22%

Revenue CAGR 3Y+123.20%

P/E Ratio0.0

PEG Ratio—

FCF Yield-10.52%

Debt / Equity0.06

Interest Coverage999.0x

No credit card required

Already have an account? Sign in to view the full analysis for RLAY.